Europe Update – Life Sciences Products and COVID-19: From Clinical Trials to Regulatory Flexibility

Published date22 April 2020
Subject MatterLife Sciences,European Commission,Clinical Trials,European Medicines Agency (EMA),Coronavirus/COVID-19
AuthorUlf Grundmann,Elisabeth Kohoutek,Christina Markus,Nikki Reeves,Geneviève Michaux
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT